How to Get a Tirzepatide Prescription

Summary: Tirzepatide is prescription-only in the US. Any licensed clinician can write it if you meet FDA criteria, but cost, route, and approval speed depend on whether you go through insurance, LillyDirect, or a telehealth platform.

This content is for informational purposes only and is not medical advice. Always consult a qualified healthcare provider before starting, changing, or stopping any medication.

The short answer: any US-licensed clinician with prescribing authority can write a tirzepatide prescription if you meet the FDA-approved criteria. That includes your primary care doctor, an endocrinologist, an obesity medicine specialist, or a telehealth provider licensed in your state. The bottleneck is rarely finding a prescriber. The bottleneck is documentation, insurance prior authorization, and picking the route that actually fits your wallet.

Here is the full playbook for 2026, from eligibility to script in hand.

Who can prescribe tirzepatide

Tirzepatide is a federally scheduled prescription drug. It is not over the counter, it is not legally available without a prescription, and the prescriber must be licensed in the state where you live. Within that rule, the field is wide.

Prescriber typeTypical use caseSpeed
Primary care physician (PCP)First-line, insurance-friendly, full records1 to 6 weeks
EndocrinologistType 2 diabetes, complex hormone cases4 to 12 weeks (referral)
Obesity medicine specialistHigher BMI, prior medication failures, comorbidities2 to 8 weeks
Nurse practitioner / PASame authority as MD in most statesSame as the practice
Telehealth clinicianCash pay, fast turnaround, weight loss focus24 to 72 hours

Nurse practitioners and physician assistants have full prescribing authority for GLP-1 medications in nearly every US state. A telehealth NP can write the same legal prescription as a board-certified endocrinologist. The clinical depth differs; the legal validity does not.

The eligibility rules the FDA actually wrote

Tirzepatide has two brand names because it has two indications. Read these criteria carefully because they determine which prescription your provider can write and which insurance pathway you can use.

Mounjaro is approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [1]. To qualify, you need a documented T2D diagnosis. That means an A1C of 6.5 percent or higher, a fasting plasma glucose of 126 mg/dL or higher on two separate tests, or a 2-hour plasma glucose of 200 mg/dL or higher during an oral glucose tolerance test. Mounjaro is not approved for prediabetes, and it is not approved for weight loss as a standalone indication.

Zepbound is approved for chronic weight management in adults with obesity (BMI 30 or higher), or overweight (BMI 27 or higher) with at least one weight-related comorbidity such as hypertension, dyslipidemia, type 2 diabetes, obstructive sleep apnea, or cardiovascular disease [2]. Zepbound was also approved in late 2024 for moderate-to-severe obstructive sleep apnea in adults with obesity, which opened a second insurance pathway that does not depend on the weight loss benefit alone.

Same molecule, two labels, two different rulebooks. Your prescriber picks the label that matches your diagnosis.

What documentation actually helps your case

The prescription itself takes thirty seconds to write. The chart note that backs it up is what matters when insurance asks. Bring or have on file:

  • Height and weight measured in the past 90 days. Self-reported numbers usually work for telehealth; in-person clinics will measure you themselves. Both feed into the BMI calculation that anchors the chart note.
  • A1C from the past 6 months if you are pursuing Mounjaro or have any T2D history. This is the single most powerful number for a diabetes prescription and is often required for prior authorization.
  • Documented comorbidities. Hypertension diagnosis with blood pressure readings, sleep apnea with a positive sleep study, dyslipidemia with a lipid panel, type 2 diabetes with an A1C, cardiovascular disease with imaging or specialist notes. Pick the ones that apply and bring proof.
  • Prior weight loss attempts. Many insurance plans require documentation that you tried lifestyle changes for 6 months, attended a structured weight program, or trialed an older medication like phentermine, orlistat, or naltrexone-bupropion (Contrave). This is the most common gating step in 2026 prior authorization rules.
  • Current medication list. Your prescriber needs to flag interactions, especially with insulin and sulfonylureas where hypoglycemia risk rises.
  • Family history of medullary thyroid carcinoma or MEN2. Both are boxed-warning contraindications on the Mounjaro and Zepbound labels [1][2]. Personal history of pancreatitis also requires a closer look.

Write this down before your appointment. A clinician who has the data in front of them at minute three of a fifteen-minute visit can write a clean prescription. A clinician who has to dig through your records can write the prescription too, just slower and with more back-and-forth.

Route 1: telehealth, the fastest path

For cash-pay patients without insurance coverage for weight loss medications, telehealth is the standard 2026 route. The reason is timing: most platforms turn around a consultation, a prescription, and shipped medication in 2 to 7 days. Compare that to the 4 to 12 weeks a new-patient appointment with an obesity medicine specialist can take.

The mechanics are consistent across platforms. You complete an online intake covering health history, current medications, height and weight, and goals. A licensed clinician reviews the intake, sometimes on a 10 to 15 minute video call and sometimes asynchronously by message. If you qualify, the prescription goes to a partner pharmacy, often a 503A compounding pharmacy, and ships to your door.

The big telehealth names in 2026:

  • Hims/Hers, Ro, Henry Meds, Mochi Health, Sequence (WeightWatchers Clinic), Eden, Form Health, LifeMD. Pricing ranges from roughly $200 to $500 per month all-in. Most bundle the consultation, the prescription, and the medication into one monthly fee.
  • LillyDirect. Eli Lilly's own self-pay channel. You consult with a partner clinician (FORM Health or LifeMD), and if approved, Lilly ships authentic Zepbound vials at $349 to $599 per month depending on dose [5]. This is the cleanest path to the FDA-approved brand product without insurance.

Telehealth makes sense if you do not have insurance coverage for weight management, you want the prescription fast, and you can pay $200 to $600 per month. It does not make sense if your insurance covers Zepbound or Mounjaro at a $25 to $100 copay, because going around insurance costs you money for no benefit.

Route 2: in-person clinic with insurance

If your plan does cover tirzepatide, this is the cheapest legitimate route by a wide margin. Insurance copays for Zepbound and Mounjaro run $25 to $100 per month when the formulary includes the drug and prior authorization clears.

The process:

  1. Schedule with your PCP. Mention the weight management or diabetes goal up front when booking so the visit gets enough time. Twenty minutes is the minimum; some practices block thirty for a GLP-1 consultation.
  2. Bring the documentation above. Especially the prior weight loss attempts and the comorbidity proof.
  3. Ask the clinician to check your formulary in real time. Most EHRs can pull formulary tier data while you are in the room. If Zepbound is on tier 3 with prior authorization, you know the path before you leave.
  4. Get the script sent and wait for the prior auth determination. Prior auth on a GLP-1 takes 3 to 14 business days at most large insurers. Some plans auto-approve when the documentation is clean. Most require a back-and-forth.

If your PCP is uncomfortable prescribing GLP-1s, ask for a referral to an obesity medicine specialist or an endocrinologist. Both write tirzepatide regularly and both can take your insurance.

Insurance, prior authorization, and denial appeals

This is where most patients lose weeks. The rules vary by insurer, but the patterns are consistent.

What plans typically require for Zepbound approval:

  • BMI of 30+, or 27+ with at least one documented comorbidity (the FDA criteria, copy-pasted into the prior auth form)
  • Documentation of a 6-month supervised weight loss attempt within the last 2 years
  • Step therapy: trial of phentermine, orlistat, or naltrexone-bupropion first in some plans
  • Provider attestation that the patient will use the medication as part of a comprehensive program including diet and exercise

What plans typically require for Mounjaro approval:

  • Documented type 2 diabetes (A1C, fasting glucose, or OGTT result)
  • Trial of metformin first, unless contraindicated
  • Sometimes a trial of an older GLP-1 (semaglutide, dulaglutide) before approving tirzepatide

Common reasons for denial:

  1. Off-formulary. Your plan does not cover Zepbound at all. Many employer plans exclude weight loss medications entirely. This is the hardest denial to overturn because it is policy, not a clinical judgment.
  2. BMI documentation gap. The prior auth requires a measured BMI from the past 90 days and your chart has one from 18 months ago.
  3. Missing comorbidity documentation. You have sleep apnea, but the chart has no sleep study on file. Get the study scanned in.
  4. Step therapy not completed. You did not try the cheaper drug first.
  5. Prescriber not credentialed. Some plans require obesity medicine board certification or endocrinology to approve weight loss GLP-1s.

If denied, you have the right to appeal. The first appeal goes back to the insurer with a letter of medical necessity from your prescriber. Include the specific FDA-approved indication, the BMI math, every comorbidity with a diagnosis code, and the documentation that addresses the denial reason. If that fails, escalate to an external review through your state insurance department. External reviews approve a meaningful share of GLP-1 denials when the medical case is solid.

The appeal framework is the same for tirzepatide as it is for any high-cost specialty medication. Patience and paperwork beat phone calls.

What to bring to your appointment

The clinician will measure or confirm the above, document medical necessity, and choose Mounjaro or Zepbound based on the diagnosis that fits. A 2.5 mg starter dose is standard for the first 4 weeks, with titration up by 2.5 mg every 4 weeks as tolerated [1][2]. The starting dose conversation is short. The eligibility conversation is the one that determines whether you walk out with a prescription.

What disqualifies you (or makes a prescriber hesitate)

The FDA labels list specific contraindications and warnings that prescribers screen for:

  • Personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Boxed warning on both labels [1][2]. This is an absolute contraindication.
  • History of severe hypersensitivity to tirzepatide or any excipient.
  • Pregnancy. Tirzepatide is not recommended in pregnancy; women of reproductive age should use effective contraception. Oral contraceptive effectiveness may be reduced after a tirzepatide dose escalation, so non-oral contraception or backup is advised for 4 weeks after each dose change.
  • History of pancreatitis. Not an absolute contraindication, but most prescribers will consider alternatives.
  • Severe gastroparesis. Tirzepatide slows gastric emptying further; severe baseline gastroparesis is a relative contraindication.
  • Type 1 diabetes. Tirzepatide is not approved for T1D and is not a substitute for insulin.

Outside these, most adults who meet the BMI or diabetes criteria can get a prescription written. The friction is documentation and cost, not eligibility.

Concrete next steps

If you have insurance with weight management coverage: call the number on your card, ask if Zepbound is on the formulary, ask what prior authorization requires, then book your PCP. Total time to script: 2 to 4 weeks if the prior auth clears on first submission.

If you have insurance without weight management coverage but you have type 2 diabetes: same call, but ask about Mounjaro. The diabetes pathway is much more likely to be covered. Total time: 1 to 3 weeks.

If you are paying cash and want the brand product: go to LillyDirect [5]. Authentic Zepbound, $349 to $599 per month, ships in about a week.

If you are paying cash and want the cheapest legitimate route: pick a reputable telehealth platform with a 503A pharmacy partner. Compounded tirzepatide runs $200 to $400 per month with full physician oversight. Total time: 2 to 7 days.

If you cannot get coverage and cannot afford cash pay: ask your prescriber about the Zepbound Savings Card (up to $463 off without insurance for eligible commercial-plan patients) or the Mounjaro Savings Card ($25/month for commercially insured T2D patients) [5]. Patient assistance through Lilly Cares may also apply if you are under specific income thresholds.

Common questions about getting a tirzepatide prescription

Can a nurse practitioner prescribe tirzepatide?
Yes. Licensed nurse practitioners and physician assistants with prescriptive authority can legally write tirzepatide in nearly every US state, in-person or via telehealth.
Do I need labs before getting a tirzepatide prescription?
Not always. In-person prescribers usually order baseline labs (fasting glucose, A1C, kidney and liver function, lipid panel). Many telehealth platforms start without labs and monitor during treatment.
How do I qualify for tirzepatide for weight loss?
BMI of 30 or higher, or BMI of 27 to 29.9 with at least one weight-related comorbidity such as hypertension, type 2 diabetes, sleep apnea, dyslipidemia, or cardiovascular disease. Those are the FDA criteria for Zepbound.
Is tirzepatide approved for weight loss?
Yes. Zepbound (tirzepatide) is FDA-approved for chronic weight management in adults with obesity, and for moderate-to-severe obstructive sleep apnea in adults with obesity. Mounjaro is the same molecule but approved only for type 2 diabetes.
How do I get tirzepatide online?
Through a telehealth platform licensed in your state, or through LillyDirect for the brand product. You complete an intake, do a video or asynchronous consult, and if approved the prescription ships to your door within a week.
How can I get tirzepatide cheap?
If insurance covers it, the copay route ($25 to $100/month) is cheapest. Without insurance, compounded tirzepatide through telehealth ($200 to $400/month) is the next tier. LillyDirect Self Pay ($349 to $599/month) gets you brand-name product without insurance. Manufacturer savings cards can drop branded copays further if you have commercial insurance.
What if my insurance denies tirzepatide?
File an appeal with a letter of medical necessity from your prescriber. Include BMI, documented comorbidities, and any failed prior medications. If the internal appeal fails, request external review through your state insurance department.
Can my PCP prescribe tirzepatide?
Yes. Primary care physicians can and do prescribe tirzepatide regularly. If your PCP is uncomfortable with GLP-1s, ask for a referral to obesity medicine or endocrinology.
Do I need a type 2 diabetes diagnosis to get tirzepatide?
No, but the brand you get depends on your diagnosis. With type 2 diabetes you can get Mounjaro. Without diabetes, you can still qualify for Zepbound for weight management if you meet the BMI thresholds.
How long does it take to get a tirzepatide prescription?
Telehealth: 1 to 3 days from intake to ship. LillyDirect: about a week. Insurance through a PCP with prior authorization: 2 to 6 weeks. Specialist referrals: 4 to 12 weeks if booking new.

What this page does not cover

This is the prescription access guide. Adjacent topics, like comparing specific telehealth platforms head-to-head, what tirzepatide actually costs at each retail and discount option, how to titrate the dose week by week, and what side effects to expect in month one, have their own dedicated pages on this site. The path from "I want tirzepatide" to "I have a prescription" is the one mapped above. The path after that prescription is its own conversation.

References

  1. FDA Mounjaro (tirzepatide) prescribing information
  2. FDA Zepbound (tirzepatide) prescribing information
  3. Jastreboff AM et al, Tirzepatide once weekly for treatment of obesity, NEJM 2022 (SURMOUNT-1)
  4. FDA Drug Shortages: tirzepatide injection resolution notice
  5. Lilly Zepbound and Mounjaro savings and pricing information